DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG)

ACMG Board of Directors

doi:10.1038/s41436-020-01083-9

DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG)

ACMG Board of Directors

Quantitative Health Sciences

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	979-988
Number of pages	10
Journal	Genetics in Medicine
Volume	23
Issue number	6
DOIs	https://doi.org/10.1038/s41436-020-01083-9
State	Published - Jun 2021

ASJC Scopus subject areas

Genetics(clinical)

Access to Document

10.1038/s41436-020-01083-9

Cite this

@article{754c02b0ac484baeb1b3ce928e7b9659,

title = "DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG)",

author = "{ACMG Board of Directors} and Bean, {Lora J.H.} and Scheuner, {Maren T.} and Murray, {Michael F.} and Biesecker, {Leslie G.} and Green, {Robert C.} and Monaghan, {Kristin G.} and Palomaki, {Glenn E.} and Sharp, {Richard R.} and Trotter, {Tracy L.} and Watson, {Michael S.} and Powell, {Cynthia M.}",

note = "Funding Information: Funding and support listed here did not support development of this document unless listed in the Acknowledgements section. L.J.H.B. is currently an employee of PerkinElmer, Inc. M.F.M. reports receiving grants from Regeneron Pharmaceuticals, and personal fees from Invitae and 54gene all outside the submitted work. L.G.B. is an uncompensated member of the Illumina Medical Ethics Advisory Board. He receives in-kind research support from ArQule, Inc., now wholly owned by Merck, Inc. He receives honoraria from Cold Spring Harbor Press for editing. R.C.G. receives compensation for advising the following companies: AIA, SavvySherpa, Verily, Wamberg; and is cofounder of Genome Medical, Inc. G.E.P. reports current grant/research support from PerkinElmer, Inc., Abbott Diagnostics, and Ansh Laboratories, past grant/research report from Natera, Inc. and Sequenom Laboratory, as well as consulting fees paid to employer from Illumina, LabCorp, and Roche, and personal reimbursement as coauthor of multiple UptoDate prenatal screening topics (all are outside of the submitted topic). The other authors declare no competing interests.",

year = "2021",

month = jun,

doi = "10.1038/s41436-020-01083-9",

language = "English (US)",

volume = "23",

pages = "979--988",

journal = "Genetics in Medicine",

issn = "1098-3600",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - DNA-based screening and personal health

T2 - a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG)

AU - ACMG Board of Directors

AU - Bean, Lora J.H.

AU - Scheuner, Maren T.

AU - Murray, Michael F.

AU - Biesecker, Leslie G.

AU - Green, Robert C.

AU - Monaghan, Kristin G.

AU - Palomaki, Glenn E.

AU - Sharp, Richard R.

AU - Trotter, Tracy L.

AU - Watson, Michael S.

AU - Powell, Cynthia M.

N1 - Funding Information: Funding and support listed here did not support development of this document unless listed in the Acknowledgements section. L.J.H.B. is currently an employee of PerkinElmer, Inc. M.F.M. reports receiving grants from Regeneron Pharmaceuticals, and personal fees from Invitae and 54gene all outside the submitted work. L.G.B. is an uncompensated member of the Illumina Medical Ethics Advisory Board. He receives in-kind research support from ArQule, Inc., now wholly owned by Merck, Inc. He receives honoraria from Cold Spring Harbor Press for editing. R.C.G. receives compensation for advising the following companies: AIA, SavvySherpa, Verily, Wamberg; and is cofounder of Genome Medical, Inc. G.E.P. reports current grant/research support from PerkinElmer, Inc., Abbott Diagnostics, and Ansh Laboratories, past grant/research report from Natera, Inc. and Sequenom Laboratory, as well as consulting fees paid to employer from Illumina, LabCorp, and Roche, and personal reimbursement as coauthor of multiple UptoDate prenatal screening topics (all are outside of the submitted topic). The other authors declare no competing interests.

PY - 2021/6

Y1 - 2021/6

UR - http://www.scopus.com/inward/record.url?scp=85103954233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103954233&partnerID=8YFLogxK

U2 - 10.1038/s41436-020-01083-9

DO - 10.1038/s41436-020-01083-9

M3 - Article

C2 - 33790423

AN - SCOPUS:85103954233

SN - 1098-3600

VL - 23

SP - 979

EP - 988

JO - Genetics in Medicine

JF - Genetics in Medicine

IS - 6

ER -

DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this